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In the middle of March 2019, a group of scientists and clinicians (as well as those who
wear both hats) gathered in the green campus of the Weizmann Institute of Science
to share recent scientific findings, to establish collaborations, and to discuss future
directions for better diagnosis, etiology modeling and treatment of brain malformations.
One hundred fifty scientists from twenty-two countries took part in this meeting. Thirty-
eight talks were presented and as many as twenty-five posters were displayed. This
review is aimed at presenting some of the highlights that the audience was exposed to
during the three-day meeting.
Keywords: brain malformations, brain development, neuronal migration, neuronal progenitors, brain organoids,
mouse models, mTOR, brain plasticity
EVOLUTION AND DEVELOPMENT – SPOTLIGHT ON
PROGENITORS
Our cognitive capacity is housed in the complex and well-organized cerebral cortex. Although
the basic principles, cellular mechanisms and a large proportion of the molecules that underlie
cortical development are shared by mammalian species, the human brain has exceptional
features that have been better understood in recent years, thanks to the ground-breaking
work of several distinguished labs. Prof. Arnold Kriegstein and Prof. Wieland Huttner and
colleagues have been among the pioneers of a trend of shifting from the classical rodent
model systems and focusing on human cortical development. Kriegstein and his colleagues,
study the progenitor cell population that shapes the developing human brain, in particular
the population of progenitors that is responsible for neurogenesis of the upper layers in the
human brain and resides in the outer subventricular zone (OSVZ) (see Figure 1 for an overview
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FIGURE 1 | Schematic overview of progenitor populations during human cortex development. At gestation week three the neural tube appears. Neuroepithelial cells
(NECs) that contact both the apical and pial surface divide symmetrically to exponentially amplify their number. While proceeding through the cell cycle, the nucleus
moves toward the pial surface during G1-phase, undergoes S-phase close to the pial surface and then moves back to the ventricular surface during the G2-phase,
where it will complete mitosis (M-phase) in a process known as interkinetic nuclear movements. Prior to neurogenesis, NECs lose the epithelial characteristics and
differentiate to radial glial cells (RGCs) progenitors, that maintain connected with both the apical and pial surfaces. Until week six, RGCs self-renew by symmetric cell
division, followed by asymmetric divisions generating one RGC and either a post-mitotic neuron, an intermediate progenitor (IP), or a basal RGC (bRGCs). bRGCs
are located in the outer subventricular zone and are in contact only with the pial surface. These cells can divide asymmetrically to generate either neurons or IPs,
playing a major role in human cortical surface expansion and folding (Sun and Hevner, 2014). All neurons generated by asymmetric division of RGCs, IPs and bRGCs
migrate radially along the basal process of RGCs toward the pial surface, to form a transient structure called the preplate. The preplate includes the reelin-secreting
Cajal-Retzius cells (later becoming cortical layer I) that settle right below the pial surface and are essential for the termination of cortical neuron migration. Later,
neurons migrate toward Cajal-Retzius cells and settle in the cortical plate in an inside-out fashion to form the other six layers of the cortex.
of the various cell types during human cortex development).
This area was first described in the primate cortex (Smart et al.,
2002), and was later shown to generate upper layer neurons
(Lukaszewicz et al., 2005). OSVZ progenitors include transit
amplifying intermediate progenitor (IP) cells and outer or basal
radial glia (oRG/bRG) while ventricular or apical radial glia
(vRG/aRG) reside in the ventricular zone. Delamination of vRG
cells precedes transformation of vRG cells to oRGs. vRGs and
oRGs form a discontinuous radial scaffold that spans the width of
the developing cerebral cortex. This unique organization appears
during mid-gestation approximately at the onset of neurogenesis
of the excitatory neurons of layer 3 and 4. The new scaffold
replaces the continuous vRG scaffold that is similar to the
RG fibers network in the mouse and is present in humans
at earlier stages during the birth of the excitatory neurons of
deep layers 5 and 6. This discontinuous scaffold will guide the
progeny of the transit amplifying progenitors that migrate to
the superficial cortical layers. A third population, the truncated
RG, makes contacts with blood vessels, and constitutes an
additional class of human progenitors. Characterization of the
molecular signatures and the morphotypic diversity of these
populations has progressed rapidly due to advances in single cell
RNA sequencing technologies. Such an analysis led to a better
understanding of the cellular events that allowed the evolutionary
expansion of the human cortex as well as revealed new facets
of brain malformations such as lissencephaly and microcephaly
whose study was mostly limited to rodent models. A dynamic
cellular motility that occurs during mitosis has been described
as typical to most oRG cells (Hansen et al., 2010; review Ostrem
et al., 2017). Mitotic somal translocation (MST), is a rapid,
basal-directed “jump” of the oRG soma prior to cytokinesis.
Besides this unusual migratory behavior, oRGs display a unique
transcriptional signature that consists of members of several
classes including a group of extracellular (ECM) production
genes. Changes in ECM production may reflect a potential to
influence the proliferative niche (Fietz et al., 2012) and the
physical properties of cellular environment permissive to the
formation of folds, shown in work from Prof. Huttner’s lab
(Long et al., 2018).
Work from the lab of Dr. Silvia Cappello sheds lights on
the molecular link between ECM, oRG and cortical folding.
Dr. Cappello and her team identified a secreted molecule that
binds cell membrane bound receptors and is essential for the
delamination of oRGs in human derived organoids. Similarly,
its expression in the mouse brain shifts the progenitors to a
more basal location and induces ectopic folds by remodeling
of cytoskeletal elements like F-Actin and β-catenin. The team
demonstrated that mutations in this gene are associated with
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congenital malformations and periventricular heterotopia (PH).
The transition between basic science and the clinic is not always a
straight forward one, but nonetheless fascinating. Transcriptome
profiling of oRGs led to a better understanding of the origin of
Glioblastoma multiforme, a primary cancer of the brain and one
of the most lethal ones. oRG transcriptional signatures highly
correlate with one of the cellular population identified within the
tumor and indeed, cells that display MST migratory dynamics
were identified in tumors. Moreover, a direct correlation between
MST, the stem cell-like properties and tumorigenicity of the
tumor cells was demonstrated.
The expansion of the neocortex had been attributed to
the increased proliferative behavior of the oRG/bRG and this
population is therefore an important research target. Analysis
of the transcriptional data collected from over four thousand
single cells derived from different developmental stages allowed
for the identification of genes module and signaling pathways
that are typical for oRGs (Nowakowski et al., 2017). Tracing the
key molecular players in the evolutionary neocortical expansion
has been done in parallel directions. These include the search
for new modes of gene regulation, novel gene function, and
the identification of human-specific or signaling modules that
are enriched in oRGs (Heide et al., 2017). An example of a
signaling pathway that is enriched in oRGs is, LIFR/STAT3
that was found to promote the self-renewal of oRG. This
finding has been translated to an improved in vitro modeling
system. The activation of the Hippo-Yap signaling pathway
was also correlated with the proliferative capacity of oRGs in
human and in the ferret (Kostic et al., 2019). The expansion
of the mammalian cortex was also a result of attenuation of
signaling modules. Reduced Robo1 and Robo2 signaling, and
increased expression of Dll1 in radial glia cells shifted the balance
from direct neurogenesis to the production of intermediate
progenitors (Cardenas et al., 2018). Despite the contribution
of oRG to the evolutionary increased proliferative capacity of
the human cerebral cortex, apical progenitors (vRG) are likely
to have an impact as well. Meticulous study of the cell cycle
dynamics of human and chimpanzees in 3D organoids, revealed
a cell specific lengthening of prometaphase-metaphase duration
in humans vRGs, while other mitotic phases remain unchanged
(Mora-Bermudez et al., 2016).
The human bRG population, like that of the macaque
(Betizeau et al., 2013), displays a remarkable morphological
heterogeneity that was recently described (Kalebic et al., 2019).
The complex morphology was linked to the activity of a
morpho-regulatory splice variant of PALMDELPHIN resulting
in an increase in the number of cell processes emerging from
basal radial glial cells. A link between bRG proliferation and
morphology appears to be common to both human and non-
human primates (Dehay et al., 2015; Kalebic et al., 2019).
ARHGAP11B (11B) is a human-specific gene that was shown
to enhance oRG generation and proliferation and to induce
ectopic convolutions in the otherwise smooth mouse cortical
surface (Florio et al., 2015). ARHGAP11B emerged in evolution
after a partial duplication of the ancestral ARHGAP11A, a
Rho guanosine triphosphate activating protein (RhoGAP). The
duplicated gene underwent a substitution mutation that created
a new splice variant which had lost 55 nucleotides, and gained
a human-specific C-terminal domain (Florio et al., 2016). The
novel protein product no longer possesses RhoGAP activity.
A new study from Prof. Wieland Huttner’s lab, presented by Dr.
Takashi Namba highlighted a continuous effort to understand
ARHGAP11B contribution to human cortical expansion. Unlike
the ancestral ARHGAP11A, ARHGAP11B shows a remarkable
colocalizations with the cell mitochondria, a domain-specific
effect on mitochondria metabolism and an overall augmentation
of bRG proliferation. This study adds to the accumulating data
that highlights mitochondria not merely as a supplier of energy
but rather as a regulatory center of stem cell proliferation and
differentiation (review Khacho and Slack, 2017).
Prof. Fiona Francis presented a study that focuses on the
contribution of progenitors to brain malformations. Prof. Francis
described a surprising involvement of a postsynaptic density
protein, in subcortical heterotopia, polymicrogyria (PMG),
pachygyria and global developmental delay. Prof. Francis found
that the protein is expressed during mouse cortical development
in multiple regions including the proliferative zones, the VZ
and the SVZ. Its knockdown leads to changes in the spindle
orientation of the progenitors, causing premature delamination
of the RG and thus to increased abundance of intermediate
progenitors. These changes were linked to downregulation of
F-Actin at the ventricular surface. Further elucidation of the
phenotype came from the identity of scaffolding protein partners
that are present at the postsynaptic density as well as in the
dividing progenitor.
MIGRATING CELLS – NOT THE END OF
THE ROAD
Neuronal migration is a well described phenomenon that is
essentially the movement of neurons from their place of birth
to their final location in the brain. Decades of study led to the
understanding that complex migratory events take place during
cortical development which persists into the early postnatal
ages not only in rodent but also in human (Sanai et al.,
2011). In the mouse brain, excitatory neurons born close to the
ventricular wall migrate in several modes. Early on, the neurons
that will be destined to occupy the deep layers, will extend
their leading edge to the outer most marginal zone and will
pull themselves up, a behavior known as somal translocation
(Miyata et al., 2001). Later, neurons that will delaminate from
the ventricular zone will extend and retract processes regardless
of their migratory trajectory in a mode of migration known as
“multipolar migration” (Tabata and Nakajima, 2003). Multipolar
migrating cells form transient glutamatergic synaptic contacts
with the neurons that reside in subplate and these regulate
the transition from a multi- to a bipolar morphology (Ohtaka-
Maruyama et al., 2018). Following a transition to a bipolar
morphology the cells will migrate in RG-dependent locomotion
toward the pial surface. Just beneath the outermost cell-dense
region of the CP, the primitive cortical zone (PCZ), cells will
extend and retract their leading edge, a mode of migration that
was thus named “terminal translocation”(Sekine et al., 2011).
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Prof. Kazunori Nakajima, a leader of a prominent research team,
described a new type of migration which he rightfully named
“erratic migration.” Cell that are “erratic” will not comply to
the radial trajectories seen in most radially migrating neurons,
as they will follow irregular paths and will change directions
frequently. Lineage tracing based on photoconversion of KikGR
was done in organotypic slice cultures with combination of
in vivo genetically based tracing and revealed that these rogue
cells are in fact glial progenitors that are born during prenatal
stages. These observations led to the discovery of yet another
migration mode; blood vessel guided migration. Prof. Nakajima
and his team found that blood vessel guided erratic migration
promoted angiogenesis and vessels branching. They were able to
identify the molecules that mediate the attraction of the migrating
progenitors to the endothelial cell wall, and validated their
findings by loss of function studies using gene editing in both
in vivo and in vitro systems. These finding may prove to be of an
immense importance since glioma cells that are guided to blood
vessels are likely to use an overlapping molecular mechanism.
The evolutionary expansion of the human brain was
accompanied by acquisition of novel migration dynamics. Using
Macaque as a non-human primate model the lab of Prof.
Colette Dehay is studying the dynamic diversity of the OSVZ
progenitors that produce the super granular layer compartment
(SG). Prof Dehay found that the diversity of the molecular
profiles of oRGs/bRGs is mirrored by the existence of cells with
distinct morphologies (bipolar cells, cells with an apical process,
as well as cells that have a transient apical or basal process).
The bRG morphotypes differ in their neurogenic capacity, their
progeny size and the directionally of the MST that can be either
basally or apically directed. New levels of complexity of radial
migration mode can be uncovered when lamina and area specific
migration is carefully studied. Comparing SG neurons to deeper
Infragranular layer (IG) migratory neurons shows higher radial
migratory speed of the SG neurons prior to the appearance of
the cortical convolutions. Areal difference in migration modes in
area 17 and area 18 in the Macaque visual cortex were detected
only for SG and not IG neurons, with a more directed radial
movement in area 17 and more spread trajectories in area 18.
These behaviors were attributed to cell autonomous changes in
the leading-edge protrusions, and vesicular flow directionality
that are controlled by differential levels of expression of molecular
motor modulators in the different brain regions.
Neuronal migration follows either a radial or a tangential
migratory pathway, depending on the area of the developing
nervous system in which the neurons originate. Inhibitory
interneurons follow a tangential migratory route, parallel to
the surface of the ventricle. In the rodent brain, a saltatory
type of tangentially migrating interneurons was described in
which the leading edge bifurcates and the nucleus follows one
of the branches while the other retracts. The molecular basis
of the saltatory migratory pattern and its contribution to the
timed invasion of the IN to the forming cortex, was until
recently unknown. A recent manuscript from the lab of Prof.
Laurent Nguyen (Silva et al., 2018) identified the molecular
events and the importance of the non-continuous movement of
interneurons. Carboxypeptidase 1 (Ccp1), the main glutamate
chain deglutamylase, is found in the growth cone and around
the nucleus of migrating interneurons. Its conditional removal
from interneurons leads to protein hyperglutamylation and to
a steadier, less saltatory migration. Ccp1 regulates actomyosin
contractility by a novel enzymatic mode, acting on myosin light
chain (MLC) kinase, an activity that is important to correctly
time the interneurons invasion into the cortex. The untimely
invasion of the interneurons to the cortex may result in an
excitation/inhibition (E/I) imbalance in the cortical circuits
which was suggested to be the undelaying mechanism in some
neurodevelopmental brain disorders. The next challenge is
therefore to assess the relevance of these finding in human
conditions by harnessing novel modeling technologies such as
brain organoids (see next section).
The lab of Prof. Mercedes Paredes is studying the
developmental basis of brain malformation and operates
under the working hypothesis that during the prolonged
period of human brain development, cellular abnormal
maturation may occur that will lead to aberrant connectivity and
cortical dysplasia. Interneurons have an important function as
coordinators of cortical activity, and as such are of great interest
in studying the etiology of a large number of neuropathologies.
Prof. Paredes, described a unique architectural organization
of the proliferative niche of human interneurons, the hMGE
that can re-form after xenografting. She suggests that one
of the mechanisms that contributes to the rapid developing
brain of the young infant is a collection of late arriving IN
that migrate close the lateral ventricle and invade the frontal
lobe (Paredes et al., 2016). This structure was named “Arc”
and is in fact a transient medial migratory stream of late
arriving interneurons that disappears after the first year of
life. These findings change our view of the infant brain as
being more dynamic than previously appreciated having active
migratory streams that are targeting cortical regions that
expanded in human. The postnatal developmental processes of
the human brain may increase its vulnerability to insults from
the environment.
Excitatory and inhibitory neurons are not the only cell
type that exhibit impressive migratory ability. Cajal-Retzius
cells (CRs), the first-born neurons in the developing cerebral
cortex exhibit such activities. CRs are a transient population
that consists of a collection of three linages that are born
in distinct locations in the embryonic brain, all of which
produce Reelin, an instructive ECM molecule whose function
is critical for cortical lamination, and dendritogenesis (Ishii
et al., 2016). Dr. Alessandra Pierani and her colleagues
reported that the three CR linages display not only a unique
birth and dispersion routes, but also disappear in a non-
synchronous matter in a mechanism that is either bax-
dependent or bax-independent (Ledonne et al., 2016). Dr.
Pierani and her group, identified immature electrophysiological
properties of the surviving CR cells and hypothesized that
their persistence in the adult brain is connected to cortical
dysfunction. To better understand Reelin contribution to cortical
malformations, the effect of ectopic expression of several
pathological Reelin variants was assessed. This system yielded
region specific activities of the pathological variant that was
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consistent with the location and severity of malformations
detected in patients.
BRAINS IN A DISH- PUSHING THE
LIMITS
The introduction of human derived cerebral organoids jump-
started our ability to mimic human specific cellular and molecular
features of the developing brain that were until then largely
inaccessible. Prof. Juergen Knoblich, and the group led by the
late Prof. Yoshiki Sasai, established the first 3D brain organoids
system and led the way to the widespread use of this model
(Eiraku et al., 2008; Lancaster et al., 2013) (for reviews see (Di
Lullo and Kriegstein, 2017; Arlotta and Pasca, 2019; Karzbrun
and Reiner, 2019; Kyrousi and Cappello, 2019). This platform, is
used by an increasing number of labs and received a considerable
exposure in the current meeting. 3D organoids system has
proven beneficial in studies on primate evolution, as well as
studies of the cellular and molecular aspects of development
and disease etiologies (review Kyrousi and Cappello, 2019). Dr.
Silvia Cappello and her team were able to model Van Maldergem
syndrome, a neuronal migration disorder caused by mutations in
the receptor–ligand pair DCHS1 and FAT4 (Klaus et al., 2019).
The cerebral heterotopias could be recapitulated in vitro, as
evident by the presence of nodules of MAP2 + cells that were
stacked close to the ventricles of the organoids. The migratory
defect was in fact a sum of a dual contribution at the levels of the
progenitors as well as that of the migrating neurons. Disrupted
scaffold of the progenitors, was seen in the patient’s derived
organoids as well as after acute, localized reduction of DCHS1
and FAT4 mRNA, due to destabilization of the cytoskeleton.
This was accompanied by a shift in the transcriptome of vRG-
like cells from patients-derived organoids to an oSVZ/iSVZ-like
molecular signature. Mutated neurons exhibited cell autonomous
changes in their migratory dynamics, with more resting time
points and decreased velocity. This work not only dissected the
molecular and cellular events that lead to the brain malformation
and highlighted fundamental species-specific differences between
mouse and human models. Knockdown of Dchs1 or Fat4 in
the mouse led to a fundamentally different observation where
within mouse embryonic neuroepithelium resulted in increased
progenitor cell numbers and reduced neuronal differentiation
(Cappello et al., 2013).
The strength of the organoid model in uncovering human
specific cellular aspects of a migratory disorders is also evident
in the work by Bershteyn et al. (2017). Reduced dosage of
the LIS1 gene product is the cause of isolated lissencephaly
sequence (ILS) or the more severe Miller-Dieker lissencephaly
Syndrome (Reiner et al., 1993). Organoids derived from
patients’ cells, displayed an unusual MST phenotype revealing
a human specific cellular feature in the disease mechanism.
Lissencephaly oRGs translocated their soma to larger distances
but either failed to divide or displayed a longer cell cycle.
Actomyosin motors were found to be responsible for MST and
their inhibition phenocopied the lissencephalic oRG behavior
(Bershteyn et al., 2017).
Prof. Orly Reiner was able to model reduced gyrification,
one of the hallmarks of lissencephaly. Prof. Reiner and her
team were able to recapitulate the reduced folding formation
in organoids derived from CRISPR-Cas9 edited hES lines with
reduced levels of LIS1. An inherent change in the elasticity of
the cells and the forces that drive folding, was detected along
with transcriptional abnormalities that point to the extracellular
matrix as an important contributor to the cellular environment
that supports proper gyrification (Karzbrun et al., 2018).
Larger and more diverse intermediate progenitor populations
correlates with a larger brain size. Interestingly genes that are
thought to be involved in the evolutionary expansion of the
human brain are often those whose loss of function leads
to microcephaly or other brain malformation. Prof. Knoblich
presented a pipeline for the genetic screening of microcephaly
candidate genes, of which mouse modeling is often inefficient due
to a subtle manifestation of the mutations.
Modeling Autism spectrum (ASD) disorder is a challenging
task. ASD is a heterogeneous disease in multiple aspects;
in its phenotypic manifestation and severity, in its genetic
roots and in the complexity of contributing environmental
factors. Dr. Gaia Novarino, undertook this challenge and is
focusing on ASD caused by the loss of function of chromatin
modulators. She is asking not only what is the etiology of ASD
but also is there a particular developmental time window in
which the gene function is critical and whether the deleterious
effects may be reversible. Chromodomain helicase DNA binding
protein 8 (CHD8) encodes a chromatin remodeling factor.
Haploinsufficiency due to de novo mutations that span the entire
CHD8 gene define a genetic subtype of ASD (Bernier et al., 2014).
Prof. Novarino finds that the loss of function of CHD8 leads
to unbalanced vRG divisions in the ventricular zone of mutated
organoids or of mutated cells in chimeric organoids, leading
to elongated and “thinner” ventricular zones and eventually
larger organoids. Single cell RNA sequencing revealed hundreds
of differentially expressed genes many of which are known to
be linked to ASD. The transcriptional signature of the vRGs
pointed at misregulation of cell cycle genes, an activation of a
signaling pathway that potentially increases the surface area of
the ventricular zone, but also suggested the involvement of the
IN populations in the disease etiology.
Despite being extremely useful, 3D brain organoids possess
inherent limitations. One obvious limitation is the inability to
report for behavioral outcomes, which represent the clinical
readout of most if not all brain disorders. In addition, while
the human cortex contains hundreds of cell types with distinct
transcriptional signatures, it appears that it may be challenging
to represent all the cell types in organoid models. The spatio-
temporal diversification and neuronal activity add layers of
complexity to the fabric of cells that are building the human
cortex (Mayer et al., 2019; Miller et al., 2019).
Cerebral organoids contain the main cell modalities that are
found in the developing brain but their cell repertoire is simpler
than that of a primary tissue of a comparable developmental
stage (Pacitti et al., 2019). Organoids display an unpredicted
anatomy and great heterogeneity partially due to lack of areal
organization. Moreover, the large 3D organoids are hard to image
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in a non-disruptive manner and their size tends to limit nutrient
delivery. Currently, each of these limitations is being approached
experimentally or technologically. Approaches to increase the
complexity of organoids include fusion of pre-specified organoids
to a larger structure known as assembloid (review Arlotta and
Pasca, 2019), and the engineering of an artificial cellular organizer
that secrets instructive morphogens in a polarized manner
(Cederquist et al., 2019). Nutrient penetration and visibility
can be achieved by limiting the growth of the organoid in
a confined semi-transparent space (Karzbrun et al., 2018), by
constant stirring (Qian et al., 2018) or by growing organotypic
slices on an air liquid interface (Giandomenico et al., 2019).
Alternatively, the formation of vascularized organoids can be
achieved by coating the organoid with iPSC derived endothelial
cells (Pham et al., 2018) or by transplantation of human derived
organoids into an immune deficient mouse brain (Mansour et al.,
2018). Therefore, mouse models still remain extremely useful for
studying a large number of brain malformations and are often
used in conjunction with 3D organoid models.
MALFORMATIONS OF CORTICAL
DEVELOPMENT (MCDs):
CLASSIFICATION, DIAGNOSIS AND
TREATMENT
With the accessibility of more advanced imaging, it has
become apparent that MCDs are heterogeneous, with distinct
characteristics, extent, and location.
In the past, malformation such as agyria/pachygyria could
not be diagnosed before 22 weeks of gestation due to
the smooth appearance of the cerebral hemispheres, which
hampered early detection by imaging. Fetal brain malformations
may remain undiagnosed genetically since they might not
have a yet detectable genetic etiology, or they are the
result of a somatic mutation that cannot be detected by
standard prenatal genetic screens, or are not genetic. Usually
these severe malformations remain undiagnosed since they
might not be diagnosed by the time that US screening is
performed even when using standard prenatal genetic diagnostic
tests. Nevertheless, early diagnosis is obviously extremely
important in order to enable parental counseling regarding
the neurodevelopmental outcome. Prof. Gustavo Malinger,
Dr. Karina Krajden Haratz, and Prof. Tally Lerman-Sagie
demonstrated that in some cases and using high resolution
transvaginal neurosonography techniques these conditions can
be diagnosed at a very early gestational ages (13–20 weeks of
pregnancy). The malformations that can be detected include
periventricular nodular heterotopia, abnormal cortical layering,
abnormal sulcation associated with polymicrogyria, corpus
callosum agenesis, and microcephaly. Prof. Malinger and Prof.
Lerman-Sagie added to the standard ultrasound examination
the use of orthogonal planes and preformed meticulous search
for detrimental findings. Significant signs that can be detected
early include delayed cortical development, premature abnormal
sulcation, hemispheric asymmetry, irregular shape or asymmetry
of the lateral ventricles, thick or non-continuous cortex, irregular
ventricular borders, corpus callosum abnormalities and abnormal
interhemispheric fissure. Prof. Tally Lerman-Sagie also described
the pathology features of dysgyria in a fetus with a tubulinopathy.
Cortical malformations classification schemes have been
proposed to define the histological features of MCD. However,
the complexity of the malformations is often more diverse
than initially estimated using standard in utero imaging
(Malinger et al., 2007).
Prof. William Dobyns presented a plethora of examples
in which the current classification is partial or insufficient
as it fails to express the complex pathologies seen in a
single patient. He used polymicrogyria as an example of how
the interpretation changes according to advanced insights.
A more comprehensive classification scheme based on pathologic
features as well as developmental and genetic etiologies is
becoming useful as the new causative genes and deleterious
mutations are being identified as the underlying causes for
MCD (Barkovich et al., 2012). Dr. Grazia Mancini, described
an effective evaluation process to identify the etiology of
a large cohort of MCD patients. The evaluation process
include accurate classification based on neuroimaging analysis,
detailed family history and a search for gestational insults as
possible non-genetic causes of the malformation. Dr. Mancini
and her team were able to link monogenetic mutations,
chromosomal anomalies and copy number variations to patients
presenting various MCDs including microcephaly, lissencephaly,
pachygyria, subcortical band heterotopia, cobblestone-type
lissencephalies, polymicrogyria (PMG) and schizencephaly (de
Wit et al., 2008; Meuwissen et al., 2016; Oegema et al.,
2017; Dobyns et al., 2018; Vandervore et al., 2019). In this
process, the availability of next generation sequencing tools,
open access databases allowing exchange of variants and the
multidisciplinary interaction at local and international level have
proved great effectiveness.
Prof. Ute Hehr, from the University of Regensburg, leads an
“open exomes” initiative for the identification of causative genes
in a large cohort (approximately 350) of brain malformation
patients. About third of the sequence variants that Prof. Hehr
and her team identified across different brain abnormalities can
be classified as pathogenic variants yet a similar proportion are
of unknown significance. Prof. Hehr described two pathological
synonymous variants in F-actin-binding cytoplasmic cross-
linking phosphoprotein Filamin A (FLNA) in patients with
Periventricular Nodular Heterotopia (PNH) in which the amino
acids sequence of the predicted protein is not expected to
change and speculates that the mutation may lead to mis-
splicing of FLNA.
Prof. Nataliya DiDonato presented the concept of “Reverse
Phenotyping” which often assists her in pointing at the
correct genetic cause of particular MCD. Reverse phenotyping
takes into consideration the refinement of phenotypes on
genetic data (Schulze and McMahon, 2004). She describes
the identification of phenotypes that can be recognized as a
hallmark of a particular causative gene. Often such a phenotypic
display is very informative when a complex genetic finding
is presented and thus can assist with the diagnosis, the
Frontiers in Cellular Neuroscience | www.frontiersin.org 6 September 2019 | Volume 13 | Article 434
fncel-13-00434 September 25, 2019 Time: 17:21 # 7
Sapir et al. Brain Malformations Meeting Review
prognosis of a particular disease as well as in providing a useful
genetic counseling.
The search for the genetic basis of brain malformations is
not limited to protein coding gene. Dr. Stefan Barakat and his
colleagues developed a genome wide unbiased and quantitative
approach to identify functional enhancers, which it is currently
being directed toward brain malformation, using 3D organoid
disease models. Barakat’s protocol named “ChIP-STARR-seq,” is
based on immunoprecipitation of chromatin using antibodies
against transcription factors or histone modifications. This
captures DNA sequences enriched for putative enhancers, that
can be tested for enhancer activity in a massively parallel-reporter
assay. To this end, DNA sequences are cloned en masse in the 3′
UTR of a reporter plasmid, that consists of a minimal promoter
that drives eGFP expression. Upon cell transfection, plasmids
that have integrated a functional enhancer will produce eGFP
mRNAs, and since the DNA sequence was cloned upstream of
the polyadenylation signal, the enhancer will also be transcribed.
Therefore, RNA-seq of GFP positive cells and sequencing of
plasmid DNA can be used to generate genome-wide enhancer
activity maps that pinpoint to functional non-coding genome
parts (Barakat et al., 2018). This approach enabled Barakat and
his team to differentiate between a pancreas specific and a
brain specific enhancer in a complex syndrome that involves
both organs.
A relatively large variety of Long non-coding RNA (lncRNA)
are expressed in the brain but their function in particular in
the neurodevelopmental context is poorly understood. Dr. Igor
Ulitsky and his team found specific lncRNAs that are required
during neurogenesis. Additionally, they identified a conserved
lncRNA that is located upstream to a chromatin modifier,
CHD2 (Chromodomain helicase DNA binding protein 2) a
gene that is implicated in early-onset epileptic encephalopathy,
developmental delay and autism. Complete deletion of the
lncRNA promoter is embryonic lethal and a single allele removal
increases the expression of CHD2 due to a cis inhibitory effect
of the lncRNA on CHD2 expression. This observation opens a
possibility to augment the normal CHD2 allele expression levels
in cases of CHD2 haploinsufficiency (Rom et al., 2019).
MCD classification schemes are based on causative genes,
include for example Tubulinopathies (caused by mutation of
TUBA1A, TUBB2A, TUBB2B, TUBB3, TUBB5, or TUBG1) and
Dyneinopathies (caused by mutation in the heavy chain 1
of cytoplasmic dynein, DYNC1H1). Prof. Nadia Bahi-Buission
showed that despite being grouped together, each class actually
contains a wide and often non-overlapping range of brain
malformations. One of the challenges that basic research
is facing, therefore, is not only discovering new causative
genes but also understanding the often-complex genotype-
phenotype correlation.
Connecting Actin genes (ACTB, ACTG1) variants to
disease phenotypes, the best-known being Baraitser-Winter
Cerebrofrontofacial (BWCFF) syndrome, was presented by Prof.
Daniela Pilz. BWCFF is associated with cortical malformations,
mainly pachygyria, in 60–70% of patients. However, mutations in
ACTG1 are also associated with isolated non-syndromic deafness
and one has been reported in isolated coloboma. Variants in
exons 5 and 6 of ACTB have recently reported with syndromic
thrombocytopenia (ACTB-AST), and ACTB haploinsufficiency
has been described with an ID syndrome associated with cardiac
and renal malformations. A specific ACTB variant (c.547C > T;
p.Arg183Trp) has been reported in Dystonia-Deafness syndrome
(Cuvertino et al., 2017; Rainger et al., 2017; Yates et al., 2017;
Latham et al., 2018; Skogseid et al., 2018).
Another suggested classification scheme, relies on a common
denominator that is not necessarily the result of single
causative gene but rather a common molecular or cellular
event. Prof. Jim Barkovich described the use of MRI to
study Dystroglycanopathies (Martin, 2005). This group of
malformations are the result of discontinues glia limitans-
basement membrane due to disturb attachment of oRGs to the
pia may be caused by mutations in different genes; including
Laminin, GPR56, LARGE, COL4A1 and Dystroglycans.
Genetic classification may not apply to all cases of MCD.
A reminder that brain malformation may not have a genetic
etiology came from several speakers. Non-genetic causes include
vascular abnormalities, described by Prof. Bruria Ben Zeev that
can lead to hypoxia, or hypoperfusion as well as other common
insults including infections of cytomegalovirus and Zika virus.
Vascular abnormalities leading to focal brain malformations
may also result from somatic and germ line mutations in
genes such as GNAQ and ENG responsible for Sturge-Weber
syndrome and hereditary hemorrhagic telangiectasia [HHT]
syndromes, respectively.
The refinement and the reproducibility of the diagnostic
criteria of brain malformations is one of the challenges which
the clinicians are currently facing, requiring a multilayer
comprehensive diagnostic approach that combines clinical,
radiological, histological, and molecular genetics characteristics,
according to Prof. Eleonora Aronica.
Novel digital pathology methods for computer-aided
analysis of images were proposed by Prof. Wlodzimierz
Klonowski. Applicability and usefulness of these methods have
been demonstrated in analysis of histopathological images
for cancer diagnosis (Klonowski et al., 2010, 2018). While
traditional evaluation of tissue images by pathologists lead to
interobserver differences and even intraobserver variations in
the assessment, these computerized methods provide simple,
fast and reproducible results. These methods can be adapted for
quantitative MRI to improve MCD diagnosis.
While striving for an improved diagnosis using existing
imaging technologies, a continuous attempt to develop new
imaging technologies is underway. Prof. Igor Meglinski
is developing a low cost, quantitative and non-invasive
laser-based imaging platform. His team is trying to
detect functional changes within the tissue, by following
changes in the blood flow, aiming at the identification
and classification of the malformation. Technological
advancements are also harnessed for the development of
effective treatment paradigms for children dealing with
cognitive disabilities. Prof. Naomi Josman, from the University
of Haifa shared the uses of Virtual Reality (VR) for the
evaluation and treatment of the patients’ everyday function and
quality of life.
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mTOR TAKES A (SECOND) HIT
The concept that deregulation of a signaling cascades is
pathogenic and likely responsible for a wide spectrum of brain
malformation echoed in the current meeting.
The mammalian target of rapamycin (mTOR) is a protein
complex that is a member of phosphoinositide 3-kinase (PI3K)-
related protein kinase family. The mTOR signaling pathway was
highlighted in several talks as key to understanding both normal
developmental sequences and pathological brain malformation.
The mTOR pathway is an established role in multiple basic
cellular events and its activation or inhibition is known to have
harmful consequences (review Crino, 2015). Mounting evidence
suggests that mTor is an important regulator of neuronal
development and is involved in a number of malformations
which are often referred to as “mTORopathies.” Mutations
in mTOR regulatory genes (TSC1, TSC2, AKT3, DEPDC5)
are associated with focal MCD, epilepsy and autistic traits in
tuberous sclerosis complex (TSC) patients, hemimegalencephaly
(HME), several megalencephaly (ME) subtypes, ganglioglioma
(GG), polyhydramnios-megalencephaly-symptomatic-epilepsy
(PMSE), familial focal epilepsy with variable foci (FFEVF) and
cortical dysplasia) (Baybis et al., 2004; Miyata et al., 2004; Crino
et al., 2006; Ljungberg et al., 2006; Dibbens et al., 2013). Prof.
Eleonora Aronica presented an overview on the field as well
challenges in identification and classification of the patients and
described routes for treatments. A spatiotemporal analysis of
gene expression patterns in Tuberous Sclerosis Complex (TSC) a
prototypic monogenic disorder of mTOR pathway dysregulation
which provides the rational mechanistic basis of a direct link
between gene mutation and brain pathology (structural and
functional abnormalities) associated with a complex clinical
phenotype including epilepsy, autism and intellectual disability
(Mills et al., 2017; Curatolo et al., 2018; Muhlebner et al.,
2019). The TSC transcriptomic network is characterized by
increased expression of genes associated with inflammatory,
innate and adaptive immune responses and extracellular matrix
organization (Mills et al., 2017). mTOR hyperactivation due to
somatic mutations in affected regions contribute to the Focal
cortical dysplasia type II (FCDII) and causes intractable epilepsy
(Lim et al., 2015) (reviewed by Marsan and Baulac, 2018). Single-
neuron genomics revealed high prevalence of somatic mutations
in the brain with the estimated frequency of approximately
0.2 events per cell (Cai et al., 2015; Evrony et al., 2016). The
contribution of local mTOR hyper activation due to mosaic de
novo somatic mutations was suggested to be the underlying cause
of HME (hemimegalencephly) lesions (Lee et al., 2012).
Prof. Stéphanie Baulac provided evidence of a somatic second-
hit mutation in the mTORC1 repressor DEPDC5 pointing at
a double-allelic hit: a brain somatic mutation identified in the
postoperative specimen in addition to a germline mutation that
sustain the focal nature of the cortical dysplasia (FCD) (Ribierre
et al., 2018). An FCD-like phenotype could be recapitulated in a
mouse model of focal and mosaic inactivation of Depdc5. Using
a sequencing panel of mTOR genes, she was able to identify
somatic mutations in mTORC1 pathway genes in >60% of FCD
II cases (Baldassari et al., 2019). The hallmarks of FCD type
II are dysmorphic neurons (type IIa), and large cells that are
known as balloon cells (type IIb) and is a prevalent cause of
refractory epilepsy (Blumcke et al., 2011). She showed these
pathological cells carry the mutations (unpublished data). The
second hit mechanism does not necessarily involve a germline
mutation as seen in the work presented by Cristiana Pelorosso,
form the lab of Renzo Guerrini. Pelorosso described an HME
patient in which both causative mutations are somatic, and
both appear in different genes of the mTOR pathway. She
analyzed brain tissue from a patient that underwent surgery due
to intractable epilepsy and found that the double mutant cells
were not typical balloon cells, but that they are cytomegalic and
display an aberrant electrophysiological activity. Pelorosso and
her colleagues found that the combination of the mutant variants
has a synergistic effect when expressed ectopically in embryonic
rat brain, despite affecting different aspect in the developing
cortex (NPCs proliferation and neuronal migration delay).
MCD AND EPILEPSY-OPEN QUESTIONS
Epilepsy is prevalent in cases of brain lesions. It is common
to heterogeneous disorders with a diverse and often unknown
underlying genetic etiology. Prof. Renzo Guerrini presented
the challenges in identifying phenotypic similarities using
neurophysiological and imaging diagnostics (for reviews please
(see Guerrini, 2005, 2006; Guerrini and Noebels, 2014; Guerrini
et al., 2014; Barkovich et al., 2015; Mei et al., 2017).
A/Prof. Richard Leventer, presented data that found that the
dysmorphic neurons in the tubers of tuberous sclerosis appear
to be denser in the tuber center compared to the tuber rim,
which is consistent with recent work suggesting the seizures
are generated from the tuber center. Additionally, A/Prof.
Leventer, finds evidence for the second hit hypothesis. Deep
sequencing of focal cortical dysplasia type IIA removed from
a patient with a germline DEPDC5 pathogenic variant allowed
the identification of a de novo somatic pathological variant
of DEPDC5. The mutation gradient hypothesis, suggests that
the epileptogenic centers display the highest density of somatic
mutations, the higher the mutation load, the greater is the
epieptogenicity (Mirzaa et al., 2016). Indeed, A/Prof. Leventer
finds evidence that support this hypothesis. The allele frequency
of second hit somatic mutations varies, with the highest mutation
load correlating with the origin of the epileptic events and
dysmorphic neuron cell density. A laser microdissection study,
shows that the somatic second hit mutations are limited to the
dysmorphic neurons in the lesion and are not present in normal
appearing nearby neurons.
Studies that are aimed at understanding the causality between
epilepsy and heterotopic lesions using animal models, were
presented by Prof. Carlos Cardoso and Dr. Jean-Bernard Manent.
FLNA is thought to influence neuronal migration and disruption
of this process was suggested to be the main cause for
periventricular nodular heterotopia (PNH) (review Guerrini and
Carrozzo, 2001). Prof. Carlos Cardoso presented data showing
that this may not be a sufficient mechanism to explain all
aspects of the malformation. Prof. Cardoso and his team, find
Frontiers in Cellular Neuroscience | www.frontiersin.org 8 September 2019 | Volume 13 | Article 434
fncel-13-00434 September 25, 2019 Time: 17:21 # 9
Sapir et al. Brain Malformations Meeting Review
novel effects of FLNA during cortical development, not only
on migrating neurons, but also on radial glia morphology and
proliferation (Carabalona et al., 2012). Additionally, conditional
knockdown of FLNA in mature neurons reveals mis-organization
of the cortical network. Cardoso and his team were able to
recapitulate epileptic seizures by locally knocking down FLNA
in mouse models and described modification in the dendritic
morphology and in the inhibitory input that the aberrant cells
receive. By attributing the epileptic event to cortical neurons that
are properly localized, Prof. Cardoso explains the relatively low
correlation between the extent of Heterotopia in the patients and
epilepsy severity.
Dr. Jean-Bernard Manent investigates the brain circuit defects
which lead to epilepsy in animal models of subcortical band
heterotopia. Manent and his group created a rat model of bilateral
SBH by combining RNAi-mediated knockdown of DCX and
tripolar in utero electroporation. These rats with bilateral SBH
show spontaneous epilepsy that start at 2–3 months of age,
and seizures become more frequent and last longer as epilepsy
progresses (Sahu et al., 2019). This model allows Dr. Manent
and his group to study how the size and position of band
heterotopia differentially impact cortical circuit formation and
organization in the overlying cortex, and predispose to epilepsy
(Plantier et al., 2018).
MORPHOLOGY FUNCTION AND THE
PLASTIC BRAIN
Finally, how well can prenatal diagnosis predict the pregnancy
outcome? Prof. Daniela Prayer raised the possibility that separate
developmental routes can lead to a common desirable outcome
and thus she is challenging the notion that morphology predicts
function. Prof. Prayer, points at mechanisms that are key to
developmental plasticity namely, epigenetic modifications that
can mediate between environmental factor and the levels of gene
expression, and phenotypic plasticity, namely, the ability of a
genome to produce different phenotypes.
Prof. Prayer and her team use both structural MRI and
diffusion MRI to learn about the connectivity between different
regions of the prenatal brain. In addition, they perform resting
state fMRI and follow the function of different brain regions.
Using these technologies, combined with a long term follow
up of the diagnosed patients, Prof. Prayer presented case
studies of fetal brain malformations that had variable and
often surprising outcomes, ranging from normal development to
severe developmental impairment.
Resting state functional MRI recapitulates known findings
regarding the extent in which activity is preserved in lesion
regions which can be remarkably high. Activation within
morphologically abnormal regions is seen in majority of cases
of polymicrogyria (PMG), Schizencephaly and FCD I and in
a large proportion of FCD II and heterotopia cases (Janszky
et al., 2003). Short range connectome studies reveal evidence not
only for the preservation of the original activity in heterotopic,
“double cortex” and unilateral PMG lesions but also the presence
of ipsilateral connectivity and can predict preservation of motor
functions (Foesleitner et al., 2018). Prof. Prayer names some of
the landmarks that may assist the clinicians to improve their
predictive capabilities in cases of Corpus Callosum Agenesis
(CCA). The first is the extent of the malformation. An isolated
CCA might predict a better developmental outcome. In cases of,
isolated CCA remnant CC is most likely to be beneficial. Some
cases of isolated CCA might present no connectivity across the
hemispheres, however, their centrality may move to the temporal
lobe. While, Colpocephaly (enlargement of the lateral ventricles)
reduced hippocampal size (Knezovic et al., 2019) and abnormal
lamination in other cortical regions may be indicative to a less
desirable outcome.
FUTURE DIRECTIONS
The last part of the meeting concerned an open discussion on
major themes and points raised during the three days and focused
on the issues: (1) understanding brain development in humans:
what we know and what is still missing; (2) The issue of MCDs
classification: what are the optimal future directions to integrate
clinical, imaging, neuropathology and molecular data, and (3) the
place of MCD animals models, i.e., to identify what is available,
eventually through construction of a database and what is the
place of alternative models (organoids, iPSCs, transdifferentiated
neuronal cells).
One of the innovative aspects of this meeting was to gather
clinicians and scientists in the field and try to get them to
speak the same language and identify common research goals.
The clinicians in the audience identify as possible threats to
research development the lack of a common registry of MCD
cases through European countries, the need to improve brain
imaging in clinical setting, to define which types of follow up
sequential imaging are needed and how to organize transition
care and long term follow up studies. With advent of prenatal
genome-wide analysis made available on large scale, areas which
need to be further developed and integrated in the routine clinical
practice are the prenatal with the postnatal brain MRI imaging
or any other imaging technologies enabling accurate prediction
of the phenotypes.
Basic scientists see as a threat to discovery of genes and
mechanisms involved in MCD the fact that through NGS too
many variants and too many genes are discovered, i.e., the
tremendous heterogeneity of the molecular processes leading
to brain malformations and the lack of a standardized way
to interpret genomic variants. Hence, at the moment it does
not seem possible to create a uniform pipeline for functional
validation of variants, which requires specific approaches for each
type of gene or pathway. Many are strongly in favor of linking
basic science to clinic and apply discoveries achieved in animal
models to human disorders in a more structured way. However,
there is yet no unanimity about which model represents the
best choice. The use of the ideal closest model to humans, the
primate brain raises too many ethical issues to be considered
as valid choice, while in vitro systems with human cells seem
to progressively replace the role and overcome the limitations
of mouse models. In this respect the creation of tissue banking
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and the way to connect these facilities would greatly facilitate
research. Follow-ups on this meeting can be seen in the activities
of COST Action CA16118; www.neuro-mig.org.
CONCLUDING REMARKS
As summarized above, during this 3-day meeting a broad variety
of talks related to basic and clinical research on MCD were
presented. In an inspiring environment, fruitful discussions
between clinicians, neuroscientists, geneticists, gynecologists,
pathologists and other specialists took place that we feel will
be the starting point for many collaborations and will enable
further future advancements in the field that ultimately will lead
to benefits for affected individuals and their families.
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